Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$262K Sell
5,007
-404
-7% -$21.4K 0.23% 121
2026
Q1
$299K Sell
5,411
-126
-2% -$6.83K 0.3% 98
2025
Q4
$272K Buy
+5,537
New +$258K 0.28% 98

Other funds holding GSK

Invested Advisors's GSK Position: Q2 2026 in Review

Invested Advisors reduced its GSK (GSK) stake by 7.5% in Q2 2026, selling an estimated $21.4K and leaving 5,007 shares worth $262K. The position accounts for 0.23% of the portfolio, ranked #121.

Invested Advisors first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $299K in Q1 2026. 541 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Invested Advisors held 5,007 shares of GSK worth $262K as of Q2 2026.
  • Invested Advisors sold 404 GSK shares in Q2 2026, an estimated $21.4K.
  • GSK made up 0.23% of Invested Advisors's portfolio in Q2 2026, its #121 holding.
  • Invested Advisors first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • Invested Advisors's GSK position peaked at $299K in Q1 2026.
  • 541 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Invested Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.